Psychoeducational Course for Suicide Prevention
Launched by ST. OLAVS HOSPITAL · Jun 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special course designed to help prevent suicide in people who are at risk. The course will provide important information about suicide, help participants identify what triggers their feelings of distress, and teach them how to recognize early warning signs of increased risk. At the end of the course, participants will work on creating a personal safety plan to help them manage their feelings and reduce their risk of suicide. The program involves both patients and their family members to ensure a supportive environment. In this study, some participants will attend the full course while others will have a shorter individual session focused on their safety plan. Everyone will also continue to receive their usual treatment during this time.
To be eligible for the trial, participants should have a history of suicide attempts or significant suicidal thoughts, as confirmed by their doctor. This trial is open to all adults aged 18 and older, but individuals who are not fluent in Norwegian, have certain mental health conditions, or are unable to give informed consent cannot participate. The study is currently recruiting participants, and it aims to compare the effectiveness of the psychoeducational course against the shorter session to see which approach helps better in reducing the risk of suicide.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a suicide attempt, suicidal behavior, or risk of suicidal behavior and a clinician evaluating that the patient has an intention to die
- • Patients with a suicide attempt or suicidal behavior defined as "a self-inflicted, potentially injurious behavior with a non-fatal outcome for which there is evidence of intention of death and/or considered to have had or been close to a suicidal crisis syndrome.
- Exclusion Criteria:
- • Not being sufficiently fluent in Norwegian to provide informed consent, valid responses on psychometric testing or to benefit from a psychoeducative course.
- • A known diagnosis of ICD-10 F 60.3 (borderline personality disorder) with similar symptoms at previous admittances.
- • Ongoing psychosis.
- • A substance abuse condition to such a degree that they are unable to comply with the protocol and are considered to be at risk when attending psychoeducational courses.
- • Organic brain disorders or mental disabilities in such a degree that they are unable to comply with the protocol.
- • Not being able to give an informed consent
About St. Olavs Hospital
St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Levanger, Trøndelag, Norway
Trondheim, Trøndelag, Norway
Levanger, , Norway
Patients applied
Trial Officials
Katrine K Fjukstad, PhD
Principal Investigator
Helse Nord Trøndelag
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported